Capital Performance Advisors LLP Biotechnology

Capital Performance Advisors LLP

$325 Million
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
IMUX Immunic, Inc.	$34.2M	$0 0.0% of portfolio	21	Q3 2024 New
ALDX Aldeyra Therapeutics, Inc.	$298M	$0 0.0% of portfolio	17	Q3 2024 New
TBPH Theravance Biopharma, Inc.	$618M	$0 0.0% of portfolio	5	Q3 2024 New
LRMR Larimar Therapeutics, Inc.	$174M	$0 0.0% of portfolio	18	Q3 2024 New
SMMT Summit Therapeutics Inc.	$3.56B	$0 0.0% of portfolio	36	Q3 2024 New
XBIT X Biotech Inc.	$136M	$0 0.0% of portfolio	1	Q3 2024 New
OVID Ovid Therapeutics Inc.	$66.9M	$0 0.0% of portfolio	146	Q3 2024 New
KMPH Kempharm, Inc	$170M	$0 0.0% of portfolio	40	Q3 2024 New
QSI Quantum Si Inc	$418M	$0 0.0% of portfolio	355	Q3 2024 New
RGNX Regenxbio Inc.	$361M	$0 0.0% of portfolio	11	Q3 2024 New
AXSM Axsome Therapeutics, Inc.	$3.59B	$0 0.0% of portfolio	10	Q3 2024 New
WVE Wave Life Sciences Ltd.	$1.13B	$0 0.0% of portfolio	13	Q3 2024 New
VYGR Voyager Therapeutics, Inc.	$229M	$0 0.0% of portfolio	16	Q3 2024 New
KRYS Krystal Biotech, Inc.	$4.1B	$0 0.0% of portfolio	4	Q3 2024 New
MRUS Merus N.V.	$1.99B	$0 0.0% of portfolio	4	Q3 2024 New
MRSN Mersana Therapeutics, Inc.	$133M	$0 0.0% of portfolio	11	Q3 2024 New
CELC Celcuity Inc.	$197M	$0 0.0% of portfolio	10	Q3 2024 New
RYTM Rhythm Pharmaceuticals, Inc.	$3.34B	$0 0.0% of portfolio	16	Q3 2024 New
SCPH Sc Pharmaceuticals Inc.	$99.2M	$0 0.0% of portfolio	85	Q3 2024 New
XFOR X4 Pharmaceuticals, Inc	$49.4M	$0 0.0% of portfolio	760	Q3 2024 New
RCUS Arcus Biosciences, Inc.	$1.1B	$0 0.0% of portfolio	10	Q3 2024 New
COGT Cogent Biosciences, Inc.	$543M	$0 0.0% of portfolio	37	Q3 2024 New
SRRK Scholar Rock Holding Corp	$2.21B	$0 0.0% of portfolio	99	Q3 2024 New
CRNX Crinetics Pharmaceuticals, Inc.	$2.66B	$0 0.0% of portfolio	8	Q3 2024 New
REPL Replimune Group, Inc.	$552M	$0 0.0% of portfolio	76	Q3 2024 New
YMAB Y M Abs Therapeutics, Inc.	$334M	$0 0.0% of portfolio	3	Q3 2024 New
ARVN Arvinas, Inc.	$1.03B	$0 0.0% of portfolio	6	Q3 2024 New
ALLO Allogene Therapeutics, Inc.	$338M	$0 0.0% of portfolio	41	Q3 2024 New
TRVI Trevi Therapeutics, Inc.	$244M	$0 0.0% of portfolio	134	Q3 2024 New
IDYA Ideaya Biosciences, Inc.	$1.22B	$0 0.0% of portfolio	1	Q3 2024 New
AKRO Akero Therapeutics, Inc.	$1.24B	$0 0.0% of portfolio	20	Q3 2024 New
IMVT Immunovant, Inc.	$3.55B	$0 0.0% of portfolio	3	Q3 2024 New
MIRM Mirum Pharmaceuticals, Inc.	$1.55B	$0 0.0% of portfolio	16	Q3 2024 New
PHAT Phathom Pharmaceuticals, Inc.	$282M	$0 0.0% of portfolio	29	Q3 2024 New
SWTX Spring Works Therapeutics, Inc.	$2.57B	$0 0.0% of portfolio	3	Q3 2024 New
RVMD Revolution Medicines, Inc.	$3.89B	$0 0.0% of portfolio	16	Q3 2024 New
STOK Stoke Therapeutics, Inc.	$367M	$0 0.0% of portfolio	32	Q3 2024 New
ZNTL Zentalis Pharmaceuticals, Inc.	$170M	$0 0.0% of portfolio	78	Q3 2024 New
ORIC Oric Pharmaceuticals, Inc.	$329M	$0 0.0% of portfolio	1	Q3 2024 New
LYRA Lyra Therapeutics, Inc.	$6.68M	$0 0.0% of portfolio	533	Q3 2024 New
NAUT Nautilus Biotechnology, Inc.	$214M	$0 0.0% of portfolio	7	Q3 2024 New
PCVX Vaxcyte, Inc.	$5.18B	$0 0.0% of portfolio	3	Q3 2024 New
RNA Avidity Biosciences, Inc.	$1.6B	$0 0.0% of portfolio	21	Q3 2024 New
GBIO Generation Bio Co.	$61.4M	$0 0.0% of portfolio	45	Q3 2024 New
NKTX Nkarta, Inc.	$118M	$0 0.0% of portfolio	29	Q3 2024 New
RLAY Relay Therapeutics, Inc.	$555M	$0 0.0% of portfolio	11	Q3 2024 New
ALXO Alx Oncology Holdings Inc	$75.8M	$0 0.0% of portfolio	20	Q3 2024 New
INZY Inozyme Pharma, Inc.	$121M	$0 0.0% of portfolio	35	Q3 2024 New
ITOS I Teos Therapeutics, Inc.	$279M	$0 0.0% of portfolio	30	Q3 2024 New
NRIX Nurix Therapeutics, Inc.	$891M	$0 0.0% of portfolio	18	Q3 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Performance Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Capital Performance Advisors LLP with notifications on news.